Literature DB >> 28273778

The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.

Daniel Golan1, Glen M Doniger2, Karl Wissemann3, Myassar Zarif3, Barbara Bumstead3, Marijean Buhse4, Lori Fafard3, Idit Lavi5, Jeffrey Wilken6, Mark Gudesblatt3.   

Abstract

BACKGROUND: The association between subjective cognitive fatigue and objective cognitive dysfunction in patients with multiple sclerosis (PwMS) has been studied, with conflicting results.
OBJECTIVE: To explore the impact of fatigue on cognitive function, while controlling for the influence of depression, disability, comorbidities, and psychotropic medications.
METHODS: PwMS completed a computerized cognitive testing battery with age- and education-adjusted cognitive domain scores. Disability (Expanded Disability Status Scale (EDSS)), cognitive fatigue, and depression were concurrently evaluated.
RESULTS: In all, 699 PwMS were included. Both cognitive fatigue and depression were significantly and negatively correlated with the same cognitive domains: information processing speed, executive function, attention, motor function, and memory (-0.15 ⩽ r ⩽ -0.14 for cognitive fatigue; -0.24 ⩽ r ⩽ -0.19 for depression). Multivariate analysis revealed significant but small independent correlations only between depression and neuropsychological test results, while cognitive fatigue had no independent correlation with objective cognitive function except for a trend toward impaired motor function in highly fatigued PwMS. Depression and cognitive fatigue accounted for no more than 6% of the variance in objective cognitive domain scores.
CONCLUSION: Cognitive fatigue is not independently related to objective cognitive impairment. Depression may influence cognitive function of PwMS primarily when it is severe. Cognitive impairment in PwMS should not be ascribed to fatigue or mild depression.

Entities:  

Keywords:  Cognitive function; computerized cognitive assessment; depression; fatigue; multiple sclerosis

Mesh:

Year:  2017        PMID: 28273778     DOI: 10.1177/1352458517695470

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

Authors:  Dejan Jakimovski; Ralph H B Benedict; Bianca Weinstock-Guttman; Osman Ozel; Tom A Fuchs; Norah Lincoff; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2021-02-15       Impact factor: 4.849

2.  Influence of Comorbidities on Healthcare Expenditures and Perceived Physical and Mental Health Status Among Adults with Multiple Sclerosis: A Propensity Score-Matched US National-Level Study.

Authors:  Sandipan Bhattacharjee; Zufan Yegezu; Kristin Kollecas; Kevin Duhrkopf; Lobat Hashemi; Nupur Greene
Journal:  Clinicoecon Outcomes Res       Date:  2021-05-13

Review 3.  Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

Authors:  Magdalena Oset; Mariusz Stasiolek; Mariola Matysiak
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-22       Impact factor: 5.081

4.  Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Authors:  Curtis M Wojcik; Meghan Beier; Kathleen Costello; John DeLuca; Anthony Feinstein; Yael Goverover; Mark Gudesblatt; Michael Jaworski; Rosalind Kalb; Lori Kostich; Nicholas G LaRocca; Jonathan D Rodgers; Ralph Hb Benedict
Journal:  Mult Scler       Date:  2019-10-22       Impact factor: 6.312

5.  Cognitive impairment and depression in patients with relapsing-remitting multiple sclerosis depending on age and neuroimaging findings.

Authors:  Oksana O Kopchak; Tetiana A Odintsova
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2021-09-08

6.  Significance of the Diagnosis of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Aneta R Borkowska; Beata Daniluk; Katarzyna Adamczyk
Journal:  Int J Environ Res Public Health       Date:  2021-10-07       Impact factor: 3.390

7.  The Complex Interplay Between Trait Fatigue and Cognition in Multiple Sclerosis.

Authors:  C Guillemin; E Lommers; G Delrue; E Gester; P Maquet; F Collette
Journal:  Psychol Belg       Date:  2022-03-16

8.  REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person 'Managing Fatigue' interventions on the impact of fatigue among persons with multiple sclerosis.

Authors:  Matthew Plow; Tanya Packer; Virgil G Mathiowetz; Kathy Preissner; Setareh Ghahari; Abdus Sattar; Francois Bethoux; Marcia Finlayson
Journal:  BMJ Open       Date:  2020-08-16       Impact factor: 2.692

9.  Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.

Authors:  Mark Gudesblatt; Karl Wissemann; Myassar Zarif; Barbara Bumstead; Lori Fafard; Jeffrey Wilken; Karen Blitz; Marijean Buhse; Sourav Santra; Christophe Hotermans; Lily Lee
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 10.  The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians.

Authors:  Christos Bakirtzis; Panagiotis Ioannidis; Lambros Messinis; Grigorios Nasios; Elina Konstantinopoulou; Panagiotis Papathanasopoulos; Nikolaos Grigoriadis
Journal:  Open Neurol J       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.